...
首页> 外文期刊>Annals of allergy, asthma, and immunology >ICON Diagnosis and management of allergic conjunctivitis
【24h】

ICON Diagnosis and management of allergic conjunctivitis

机译:过敏性结膜炎的图标诊断和管理

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ocular allergy (OA), interchangeably known as allergic conjunctivitis, is a common immunological hypersensitivity disorder affecting up to 40% of the population. Ocular allergy has been increasing in frequency, with symptoms of itching, redness, and swelling that significantly impacts an individual's quality of life (QOL). Ocular allergy is an often underdiagnosed and undertreated health problem, because only 10% of patients with OA symptoms seek medical attention, whereas most patients manage with over-the-counter medications and complementary nonpharmacological remedies. The clinical course, duration, severity, and co-morbidities are varied and depend, in part, on the specific ocular tissues that are affected and on immunologic mechanism(s) involved, both local and systemic. It is frequently associated with allergic rhinitis (commonly recognized as allergic rhino conjunctivitis), and with other allergic comorbidities. The predominance of self-management increases the risk of suboptimal therapy that leads to recurrent exacerbations and the potential for development of more chronic conditions that can lead to corneal complications and interference with the visual axis. Multiple, often co-existing causes are seen, and a broad differential diagnosis for OA, increasing the difficulty of arriving at the correct diagnosis(es). Ocular allergy commonly overlaps with other anterior ocular disease disorders, including infectious disorders and dry eye syndromes. Therefore, successful management includes overcoming the challenges of underdiagnosis and even misdiagnosis by a better understanding of the subtleties of an in-depth patient history, ophthalmologic examination techniques, and diagnostic procedures, which are of paramount importance in making an accurate diagnosis of OA. Appropriate cross-referral between specialists (allergists and eyecare specialists) would maximize patient care and outcomes. This would significantly improve OA management and overcome the unmet needs in global health. (C) 2019 Published by Elsevier Inc. on behalf of American College of Allergy, Asthma & Immunology.
机译:眼镜过敏(OA),可互化的过敏性结膜炎,是一种影响高达40%的人口的常见免疫基质过敏障碍。眼镜过敏频率越来越大,瘙痒,发红和肿胀症状,显着影响个人的生活质量(QOL)。眼镜过敏是一种经常是低调和患病问题,因为只有10%的OA症状患者寻求医疗注意力,而大多数患者患有过度柜台的药物和互补的非药物治疗措施。临床过程,持续时间,严重程度和共同状况变化,部分地部分地依赖于受影响的特异性眼组织和涉及的免疫机制,局部和全身性。它经常与过敏性鼻炎(通常被认为是过敏性rhino结膜炎)和其他过敏性鼻炎有关。自我管理的主要职位增加了次源治疗的风险,导致反复出现的恶化和发展更加慢性条件的可能性,这可能导致角膜并发症和干扰视觉轴。多次,通常共同存在的原因,以及对OA的广泛鉴别诊断,增加了到达正确诊断的难度。眼镜过敏通常与其他前眼病疾病重叠,包括传染病和干眼症综合征。因此,成功的管理包括通过更好地理解深入患者历史,眼科检查技术和诊断程序的细节来克服欠触的疾病甚至误诊的挑战,这对准确诊断OA至关重要。专家(过敏症家和Eyecare专家)之间适当的交叉转诊将最大限度地提高患者护理和结果。这将显着改善OA管理并克服全球健康中的未满足需求。 (c)2019年由elsevier Inc.发布代表美国过敏,哮喘和免疫学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号